A 12 month interventional study of up to 1,050 people with COPD to determine if the NuvoAir virtual-first clinical service leads to fewer moderate and severe COPD exacerbations and cardiac events, reduces healthcare utilization, and lowers the total cost of care compared to a control cohort that receives standard care only.
Twelve months of claims data in the health insurer or provider's database for baseline
ICD10 code for COPD (including emphysema and chronic bronchitis) with a severe exacerbation of COPD in the previous 12 months (defined as ER visit or hospitalization related to COPD or severity score of 2 or 3)
Cooperative, i.e., subject should be able to follow and understand instructions
Access to a phone (smartphone, cell phone, or landline)
Does not have access to a a phone (smartphone, cell phone, or landline)
Lack of cooperation, subject cannot follow and understand instructions
Other serious medical illness that, in the opinion of the PI, would interfere with the patient's participation in the study or interpretation of their data (i.e., terminal illness, unstable psychiatric condition, etc.)
Does not understand English
NuvoAir Medical PC
Lead sponsor
Optum, Inc.
Collaborator